Dr Veronica de Chavez about the Trimetazidine

Part 1:

 

What do you think about the Trimetazidine class recommendation upgrade from Iib to IIa in the 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes?​

Dr. Veronica de Chavez shares with us how the new guidelines reinforced her confidence in Trimetazidine for her patients.​

 

Part 2:

 

Why use Trimetazidine in coronary diabetic patients?​

Dr. Veronica de Chavez shares with us the clinical benefits she has observed with Trimetazidine in coronary diabetic patients.​

 

Part 3:

 

What is your experience with Trimetazidine in clinical practice?​​

Dr. Veronica de Chavez shares with us her clinical experience with Trimetazidine. ​